Advertisement
Screener

BEONE MEDICINES LTD. (ONC) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

BEONE MEDICINES LTD. Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

BEONE MEDICINES LTD. (ONC) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$283.35 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.

Discontinued › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-05-08

  • BEONE MEDICINES LTD. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$283.35M.
  • BEONE MEDICINES LTD. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was -$330.03M.
  • BEONE MEDICINES LTD. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-12-31 was -$624.75M.
  • BEONE MEDICINES LTD. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-09-30 was -$413.37M.
  • BEONE MEDICINES LTD. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$903.74M.
  • BEONE MEDICINES LTD. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$2.10B.
  • BEONE MEDICINES LTD. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was -$1.45B.
  • BEONE MEDICINES LTD. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$1.61B.
Period endComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed
2024-03-31-$283.35M
10-Q · filed 2024-05-08
2023-12-31-$903.74M
10-K · filed 2024-02-26
2023-03-31-$330.03M
10-Q · filed 2024-05-08
2022-12-31-$2.10B
10-K · filed 2024-02-26
2021-12-31-$624.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
-$1.04B
derived: sum of 2 quarters · filed 2024-02-26
-$1.51B
derived: sum of 3 quarters · filed 2024-02-26
-$1.45B
10-K · filed 2024-02-26
-$1.40B
10-K · filed 2022-02-28
2021-09-30-$413.37M
10-Q · filed 2021-11-04
-$884.82M
derived: sum of 2 quarters · filed 2021-11-04
-$822.06M
10-Q · filed 2021-11-04
-$1.32B
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30-$471.45M
10-Q · filed 2021-08-05
-$408.69M
10-Q · filed 2021-08-05
-$902.05M
derived: sum of 3 quarters · filed 2023-02-27
-$1.32B
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$62.76M
10-Q · filed 2021-05-06
-$430.60M
derived: sum of 2 quarters · filed 2023-02-27
-$848.12M
derived: sum of 3 quarters · filed 2023-02-27
-$1.19B
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31-$493.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
-$910.87M
derived: sum of 2 quarters · filed 2023-02-27
-$1.25B
derived: sum of 3 quarters · filed 2023-02-27
-$1.61B
10-K · filed 2023-02-27
-$1.59B
10-K · filed 2021-02-25
2020-09-30-$417.52M
10-Q · filed 2021-11-04
-$756.57M
derived: sum of 2 quarters · filed 2021-11-04
-$1.12B
10-Q · filed 2021-11-04
-$1.50B
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30-$339.06M
10-Q · filed 2021-08-05
-$702.65M
10-Q · filed 2021-08-05
-$1.08B
derived: sum of 3 quarters · filed 2022-02-28
-$1.41B
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$363.59M
10-Q · filed 2021-05-06
-$744.43M
derived: sum of 2 quarters · filed 2022-02-28
-$1.07B
derived: sum of 3 quarters · filed 2022-02-28
-$1.16B
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$380.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$704.43M
derived: sum of 2 quarters · filed 2022-02-28
-$796.82M
derived: sum of 3 quarters · filed 2022-02-28
-$960.45M
10-K · filed 2022-02-28
2019-09-30-$323.59M
10-Q · filed 2020-11-05
-$415.98M
derived: sum of 2 quarters · filed 2020-11-05
-$579.61M
10-Q · filed 2020-11-05
-$844.15M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$92.39M
10-Q · filed 2020-08-06
-$256.02M
10-Q · filed 2020-08-06
-$520.56M
derived: sum of 3 quarters · filed 2021-02-25
-$668.92M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$163.63M
10-Q · filed 2020-05-11
-$428.17M
derived: sum of 2 quarters · filed 2021-02-25
-$576.53M
derived: sum of 3 quarters · filed 2021-02-25
-$731.49M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$264.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$412.90M
derived: sum of 2 quarters · filed 2021-02-25
-$567.86M
derived: sum of 3 quarters · filed 2021-02-25
-$672.38M
10-K · filed 2021-02-25
2018-09-30-$148.35M
10-Q · filed 2019-11-12
-$303.32M
derived: sum of 2 quarters · filed 2019-11-12
-$407.83M
10-Q · filed 2019-11-12
-$507.60M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30-$154.96M
10-Q · filed 2019-08-08
-$259.48M
10-Q · filed 2019-08-08
-$359.25M
derived: sum of 3 quarters · filed 2020-03-02
-$241.57M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$104.52M
10-Q · filed 2019-05-09
-$204.28M
derived: sum of 2 quarters · filed 2020-03-02
-$86.61M
derived: sum of 3 quarters · filed 2020-03-02
-$146.71M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$99.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$17.91M
derived: sum of 2 quarters · filed 2020-03-02
-$42.20M
derived: sum of 3 quarters · filed 2020-03-02
-$92.74M
10-K · filed 2020-03-02
2017-09-30$117.68M
10-Q · filed 2018-11-08
$57.57M
derived: sum of 2 quarters · filed 2018-11-08
$7.02M
10-Q · filed 2018-11-08
-$30.55M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$60.11M
10-Q · filed 2018-08-09
-$110.65M
10-Q · filed 2018-08-09
-$148.23M
derived: sum of 3 quarters · filed 2019-02-28
-$183.23M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$50.55M
10-Q · filed 2018-05-09
-$88.12M
derived: sum of 2 quarters · filed 2019-02-28
-$123.12M
derived: sum of 3 quarters · filed 2019-02-28
-$147.46M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$37.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$72.58M
derived: sum of 2 quarters · filed 2019-02-28
-$96.91M
derived: sum of 3 quarters · filed 2019-02-28
-$118.35M
10-K · filed 2019-02-28
2016-09-30-$35.00M
10-Q · filed 2017-11-13
-$59.33M
derived: sum of 2 quarters · filed 2017-11-13
-$80.78M
10-Q · filed 2017-11-13
-$108.70M
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30-$24.34M
10-Q · filed 2017-08-09
-$45.78M
10-Q · filed 2017-08-09
-$73.70M
derived: sum of 3 quarters · filed 2018-02-28
-$88.43M
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31-$21.44M
10-Q · filed 2016-05-12
-$49.37M
derived: sum of 2 quarters · filed 2018-02-28
-$64.10M
derived: sum of 3 quarters · filed 2018-02-28
-$70.14M
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31-$27.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
-$42.66M
derived: sum of 2 quarters · filed 2018-02-28
-$48.69M
derived: sum of 3 quarters · filed 2018-02-28
-$59.01M
10-K · filed 2018-02-28
2015-09-30-$14.73M
10-Q · filed 2016-11-10
-$20.77M
derived: sum of 2 quarters · filed 2016-11-10
-$31.09M
10-Q · filed 2016-11-10
2015-06-30-$6.04M
10-Q · filed 2016-08-10
-$16.36M
10-Q · filed 2016-08-10
2015-03-31-$10.32M
10-Q · filed 2016-05-12
2014-12-31-$18.76M
10-K · filed 2017-03-22